These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 34823256)
1. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Saito A; Irie T; Suzuki R; Maemura T; Nasser H; Uriu K; Kosugi Y; Shirakawa K; Sadamasu K; Kimura I; Ito J; Wu J; Iwatsuki-Horimoto K; Ito M; Yamayoshi S; Loeber S; Tsuda M; Wang L; Ozono S; Butlertanaka EP; Tanaka YL; Shimizu R; Shimizu K; Yoshimatsu K; Kawabata R; Sakaguchi T; Tokunaga K; Yoshida I; Asakura H; Nagashima M; Kazuma Y; Nomura R; Horisawa Y; Yoshimura K; Takaori-Kondo A; Imai M; ; Tanaka S; Nakagawa S; Ikeda T; Fukuhara T; Kawaoka Y; Sato K Nature; 2022 Feb; 602(7896):300-306. PubMed ID: 34823256 [TBL] [Abstract][Full Text] [Related]
2. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Suzuki R; Yamasoba D; Kimura I; Wang L; Kishimoto M; Ito J; Morioka Y; Nao N; Nasser H; Uriu K; Kosugi Y; Tsuda M; Orba Y; Sasaki M; Shimizu R; Kawabata R; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; ; Sawa H; Ikeda T; Irie T; Matsuno K; Tanaka S; Fukuhara T; Sato K Nature; 2022 Mar; 603(7902):700-705. PubMed ID: 35104835 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity. Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707 [TBL] [Abstract][Full Text] [Related]
4. In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters. Furusawa Y; Kiso M; Iida S; Uraki R; Hirata Y; Imai M; Suzuki T; Yamayoshi S; Kawaoka Y EBioMedicine; 2023 May; 91():104561. PubMed ID: 37043872 [TBL] [Abstract][Full Text] [Related]
5. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda. Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497 [TBL] [Abstract][Full Text] [Related]
6. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. Liu Y; Liu J; Johnson BA; Xia H; Ku Z; Schindewolf C; Widen SG; An Z; Weaver SC; Menachery VD; Xie X; Shi PY Cell Rep; 2022 May; 39(7):110829. PubMed ID: 35550680 [TBL] [Abstract][Full Text] [Related]
7. Spike mutation D614G alters SARS-CoV-2 fitness. Plante JA; Liu Y; Liu J; Xia H; Johnson BA; Lokugamage KG; Zhang X; Muruato AE; Zou J; Fontes-Garfias CR; Mirchandani D; Scharton D; Bilello JP; Ku Z; An Z; Kalveram B; Freiberg AN; Menachery VD; Xie X; Plante KS; Weaver SC; Shi PY Nature; 2021 Apr; 592(7852):116-121. PubMed ID: 33106671 [TBL] [Abstract][Full Text] [Related]
8. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion. Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815 [TBL] [Abstract][Full Text] [Related]
9. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants. Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299 [TBL] [Abstract][Full Text] [Related]
10. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity. Khatri R; Siddqui G; Sadhu S; Maithil V; Vishwakarma P; Lohiya B; Goswami A; Ahmed S; Awasthi A; Samal S Med Microbiol Immunol; 2023 Feb; 212(1):103-122. PubMed ID: 36583790 [TBL] [Abstract][Full Text] [Related]
11. The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters. Stauft CB; Lien CZ; Selvaraj P; Liu S; Wang TT Virology; 2021 Apr; 556():96-100. PubMed ID: 33556653 [TBL] [Abstract][Full Text] [Related]
12. Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein. Wang P; Lau SY; Deng S; Chen P; Mok BW; Zhang AJ; Lee AC; Chan KH; Tam RC; Xu H; Zhou R; Song W; Liu L; To KK; Chan JF; Chen Z; Yuen KY; Chen H Nat Commun; 2021 May; 12(1):2790. PubMed ID: 33986286 [TBL] [Abstract][Full Text] [Related]
13. Why does the Omicron sub-variant spread faster than the original? Callaway E Nature; 2022 Feb; 602(7898):556-557. PubMed ID: 35177843 [No Abstract] [Full Text] [Related]
14. Characterization of a new SARS-CoV-2 variant that emerged in Brazil. Imai M; Halfmann PJ; Yamayoshi S; Iwatsuki-Horimoto K; Chiba S; Watanabe T; Nakajima N; Ito M; Kuroda M; Kiso M; Maemura T; Takahashi K; Loeber S; Hatta M; Koga M; Nagai H; Yamamoto S; Saito M; Adachi E; Akasaka O; Nakamura M; Nakachi I; Ogura T; Baba R; Fujita K; Ochi J; Mitamura K; Kato H; Nakajima H; Yagi K; Hattori SI; Maeda K; Suzuki T; Miyazato Y; Valdez R; Gherasim C; Furusawa Y; Okuda M; Ujie M; Lopes TJS; Yasuhara A; Ueki H; Sakai-Tagawa Y; Eisfeld AJ; Baczenas JJ; Baker DA; O'Connor SL; O'Connor DH; Fukushi S; Fujimoto T; Kuroda Y; Gordon A; Maeda K; Ohmagari N; Sugaya N; Yotsuyanagi H; Mitsuya H; Suzuki T; Kawaoka Y Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34140350 [TBL] [Abstract][Full Text] [Related]
16. A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern Chiem K; Morales Vasquez D; Silvas JA; Park JG; Piepenbrink MS; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Walter MR; de la Torre JC; Kobie JK; Ye C; Martinez-Sobrido L J Virol; 2021 Oct; 95(22):e0112621. PubMed ID: 34495697 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients. Eslami S; Glassy MC; Ghafouri-Fard S Gene; 2022 Mar; 813():146113. PubMed ID: 34896524 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 spike D614G change enhances replication and transmission. Zhou B; Thao TTN; Hoffmann D; Taddeo A; Ebert N; Labroussaa F; Pohlmann A; King J; Steiner S; Kelly JN; Portmann J; Halwe NJ; Ulrich L; Trüeb BS; Fan X; Hoffmann B; Wang L; Thomann L; Lin X; Stalder H; Pozzi B; de Brot S; Jiang N; Cui D; Hossain J; Wilson MM; Keller MW; Stark TJ; Barnes JR; Dijkman R; Jores J; Benarafa C; Wentworth DE; Thiel V; Beer M Nature; 2021 Apr; 592(7852):122-127. PubMed ID: 33636719 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies. Müller K; Girl P; Giebl A; Gruetzner S; Antwerpen M; Khatamzas E; Wölfel R; von Buttlar H Virus Genes; 2021 Dec; 57(6):502-509. PubMed ID: 34608598 [TBL] [Abstract][Full Text] [Related]
20. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage. Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]